Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reck

Showing results (1001-1010 of 1,518) with videos related to

Pageof 152
Sort By:
Frontiers in Psychiatry|April 23, 2024
Empathy and psychopathology in children and adolescents: the role of parental mental illness and emotion regulationArleta A Luczejko, Klara Hagelweide, Rudolf Stark, et al.
ESMO Open|August 2, 2017
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancerBirgit Gaschler-Markefski, Patricia Sikken, John V Heymach, et al.
Genetics and Molecular Biology|May 1, 2020
Phylogenetic niche conservatism and plant diversification in South American subtropical grasslands along multiple climatic dimensionsMichel J F Barros, Gustavo A Silva-Arias, Ana Lúcia Anversa Segatto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2010
Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation studyMartin Reck, Norbert Frickhofen, Susana Cedres, et al.
Neuroimage|December 8, 2011
Task-specific modulation of effective connectivity during two simple unimanual motor tasks: a 122-channel EEG studyDamian M Herz, Mark S Christensen, Christiane Reck, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|January 18, 2008
[Concordance between clinical and pathological staging in patients with stages I or II non-small cell lung cancer subjected to surgical treatment]Pedro Augusto Reck Dos Santos, Rodrigo Sponchiado da Rocha, Maurício Pipkin, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2012
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatinMartin Reck, Nick Thatcher, Egbert F Smit, et al.
Clinical Lung Cancer|August 3, 2024
Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung CancerMartin Reck, Tuli De, Luis Paz-Ares, et al.
Clinical Lung Cancer|February 3, 2024
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene AlterationsDelvys Rodriguez-Abreu, Joaquim Bosch-Barrera, Jhanelle E Gray, et al.
Future Oncology (London, England)|May 30, 2023
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLCBenjamin P Levy, Enriqueta Felip, Martin Reck, et al.
Pageof 152

Showing results (1001-1010 of 1,518) with videos related to

Sort By:
Pageof 152
Frontiers in Psychiatry|April 23, 2024
Empathy and psychopathology in children and adolescents: the role of parental mental illness and emotion regulationArleta A Luczejko, Klara Hagelweide, Rudolf Stark, et al.
ESMO Open|August 2, 2017
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancerBirgit Gaschler-Markefski, Patricia Sikken, John V Heymach, et al.
Genetics and Molecular Biology|May 1, 2020
Phylogenetic niche conservatism and plant diversification in South American subtropical grasslands along multiple climatic dimensionsMichel J F Barros, Gustavo A Silva-Arias, Ana Lúcia Anversa Segatto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2010
Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation studyMartin Reck, Norbert Frickhofen, Susana Cedres, et al.
Neuroimage|December 8, 2011
Task-specific modulation of effective connectivity during two simple unimanual motor tasks: a 122-channel EEG studyDamian M Herz, Mark S Christensen, Christiane Reck, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|January 18, 2008
[Concordance between clinical and pathological staging in patients with stages I or II non-small cell lung cancer subjected to surgical treatment]Pedro Augusto Reck Dos Santos, Rodrigo Sponchiado da Rocha, Maurício Pipkin, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2012
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatinMartin Reck, Nick Thatcher, Egbert F Smit, et al.
Clinical Lung Cancer|August 3, 2024
Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung CancerMartin Reck, Tuli De, Luis Paz-Ares, et al.
Clinical Lung Cancer|February 3, 2024
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene AlterationsDelvys Rodriguez-Abreu, Joaquim Bosch-Barrera, Jhanelle E Gray, et al.
Future Oncology (London, England)|May 30, 2023
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLCBenjamin P Levy, Enriqueta Felip, Martin Reck, et al.
Pageof 152